Friday, 4 October 2019 | 9.00-11.30 | Conference Centre Room 1
Today's cancer survival landscape is diverse: not every patient in Europe benefits in the same way. If every country did as well as Sweden, 270,000 additional cancer patients would live five years longer. Our hypothesis: a European Cancer Plan can drive such change towards better outcomes in cancer for citizens and patients in Europe.
This session aims to trigger the discussion about a European Cancer Plan by introducing a European Cancer Dashboard (to be developed during the discussion) with key-performance indicators, including survival, return to work and rehabilitation, progress, quality of care, expenditure and innovation.
The session will also provide a strategic perspective, leveraging European and national initiatives following the EU Presidencies, as well as individual cancer patient perspectives, and reflecting on provider challenges. The recently updated Comparator Report on patient access to cancer medicines in Europe – focussing on cancer incidence, mortality, expenditure and access in Europe – will set the context for the discussion.
TIT ALBREHT, Lead, IPAAC Joint Action & Senior Health Services and Health Systems Researcher, Institute of Public Health, Slovenia
KATHI APOSTOLIDIS, President, European Cancer Patient Coalition (ECPC)
SILVIA FRANCESCHI, Scientific Director, Centro di Riferimento Oncologico, Organisation of European Cancer Institutes (OECI)
MIKE MORRISSEY, Chief Executive Officer, European Cancer Organization (ECCO)
ALEXANDER ROEDIGER, Chair, EFPIA Oncology Platform, MSD
MARTIN SEYCHELL, Deputy Director-General, European Commission Directorate-General for Health and Food Safety (DG SANTE)
NILS WILKING, Associate Professor, Institute of Health Economics, Karolinska Institutet
BARBARA WILSON, Founder, Working With Cancer
MATE CAR, Assistant Minister, Ministry of Health, Croatia
PETER O’DONNELL, Brussels correspondent, APM Health Europe